搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
来自MSN
1 个月
以岭药业(002603.SZ):化药创新药G201-Na胶囊药物临床试验申请获得受理
本品为小分子促性腺激素释放激素(GnRH)受体拮抗剂。可以阻断内源性GnRH与GnRH受体的结合,抑制促黄体生成素和卵泡刺激素等促性腺激素的合成和释放,降低睾酮和雌二醇等性激素水平,维持正常的生殖系统功能。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Tapped as energy secretary
Jake Paul defeats Mike Tyson
Flash bombs target home
Gymnastics coach dies at 82
Biden meets with Xi
Plane struck by bullet
Six Flags retires Kingda Ka
USPS to release stamp
98th World Cup win
Retires from NFL at 27
Japan's minister visits UKR
Opposes RFK Jr. nomination
Trump meets with Milei
Lays off over 400 workers
Court: Execution can resume
Named WH press secretary
Probing hateful emails, texts
Sentenced to life in prison
Overtime pay rule blocked
Hit by stray bullet
World Series winner dies
Flight avoids mountain
Severe mpox strain in CA
Instruments up for auction
Musk expands OpenAI suit
Opposes Gaetz report
Wrongful death lawsuit filed
Fritz reaches title match
Attends UFC fight in NYC
反馈